Head and Neck Cancer Management

Asian Pacific Journal of Cancer Care

article

Salima Shams¹ 

[1] Aga Khan University, School of Nursing and Midwifery

关键词: Head and Neck Cancer;    chemotherapy;    systemic therapy;    targeted therapy;    toxicities;   

DOI  :  10.31557/apjcc.2023.8.1.263-265

学科分类：内科医学

来源: West Asia Organization for Cancer Prevention

【 摘 要 】

Head and Neck Cancer (HNC) is a broad category of cancer, comprises of cancer that origin into oral cavity, pharynx, larynx, sinuses and salivary gland. Majority of oral cancer cases reported in Pakistan are metastatic to Head and Neck and are with morphology of squamous cell carcinoma. Locally advance, un-resectable tumors are treated with systemic therapies. Commonly prescribe systemic therapies includes chemotherapy and targeted therapy. However, chemotherapy is the most prescribed systemic therapy because of advance presentation of cases with the morphology of Squamous cell carcinoma. Cisplatin and Carboplatin are drug of choice in HNC treatment. Chemotherapy treatment result in many toxicities such as nausea-vomiting, nephrotoxicity, cystitis, diarrhea, mucositis, ototoxicity, myelosuppresion, allergic reaction and others. These side-effects could be overcome through pharmacological and non-pharmacological interventions.

【 授权许可】

CC BY